Patrick advises companies, founders and investors on a range of tax issues and business transactions – including mergers, acquisitions, divestitures, debt and equity financings, joint ventures, and inbound and outbound investments. He also maintains an active pro bono practice helping organizations achieve and preserve tax-exempt status.
Contentsquare Enters Definitive Agreement to Acquire Loris AI
July 30, 2025
Cooley advised Contentsquare, an all-in-one experience intelligence platform, on its definitive agreement to acquire Loris AI, a conversation intelligence platform, to give business leaders a deeper, more accurate view of the full customer journey – from click to conversation.
MapLight Therapeutics Closes Oversubscribed $372.5 Million Series D
July 28, 2025
Cooley advised MapLight Therapeutics, a clinical-stage biopharmaceutical company developing targeted, novel therapies for patients with central nervous system disorders, on its oversubscribed $372.5 million Series D financing.
Hengrui Pharma and GSK Enter Agreement to Develop up to 12 Medicines
July 27, 2025
Cooley advised Hengrui Pharma, a global pharmaceutical company, on its up to $12.5 billion agreement with GSK to develop up to 12 medicines to complement GSKs extensive respiratory, immunology and inflammation (RI&I) and oncology pipeline.
Cooley advised Rubrik (NYSE: RBRK), a leading cybersecurity company, on its agreement to acquire Predibase to accelerate agentic artificial intelligence adoption from pilot to production at scale.
Cooley advised Tenable, an exposure management company, on its definitive agreement to acquire Apex Security, an innovator in securing the rapidly expanding artificial intelligence attack surface.